Wednesday, 7 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange

Novelix Pharmaceuticals Ltd

NSE: TRIMURTHI · BSE: 536565 · Retailing · 31 announcements

Share price
₹68.00
Market cap
₹119.8 Cr
Revenue (annual)
₹132.3 Cr
Net profit (annual)
₹2.56 Cr
P/E (TTM)
33.0×Sector 66.8×
Promoter holding
54.29%+4.86% QoQ
FII holding
0.00%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

20:26 IST BSE
Financial Results

Novelix Pharmaceuticals Financial Results

Novelix Pharmaceuticals reported a total annual revenue of ₹132.34 Crore and net profit of ₹2.56 Crore for FY26. The results received an unmodified audit opinion.

Value
₹132.3 Cr
20:19 IST BSE
Financial Results

Novelix Pharmaceuticals Financial Results

Novelix Pharmaceuticals approved audited FY2026 financial results and received ₹0.42 Crore from warrant conversions. Revenue reached ₹132.34 Crore with a net profit of ₹2.56 Crore.

Value
₹0.42 Cr